Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Burden of non-tuberculous mycobacterial pulmonary disease in Germany.

Diel R, Jacob J, Lampenius N, Loebinger M, Nienhaus A, Rabe KF, Ringshausen FC.

Eur Respir J. 2017 Apr 26;49(4). pii: 1602109. doi: 10.1183/13993003.02109-2016. Print 2017 Apr.

PMID:
28446559
2.

Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations.

Diel R, Lampenius N, Nienhaus A.

Pharmacoeconomics. 2015 Aug;33(8):783-809. doi: 10.1007/s40273-015-0267-x. Review.

PMID:
25774015
3.

Cost of multi drug resistance tuberculosis in Germany.

Diel R, Nienhaus A, Lampenius N, RĂ¼sch-Gerdes S, Richter E.

Respir Med. 2014 Nov;108(11):1677-87. doi: 10.1016/j.rmed.2014.09.021. Epub 2014 Oct 15.

4.

Cost-effectiveness analysis of interventions for tuberculosis control: DALYs versus QALYs.

Diel R, Lampenius N.

Pharmacoeconomics. 2014 Jul;32(7):617-26. doi: 10.1007/s40273-014-0159-5.

PMID:
24849396

Supplemental Content

Loading ...
Support Center